/CBSC
CBSC Stock - Cardiac Biotech Solutions Inc.
Healthcare|Medical - Instruments & SuppliesOTC
$0.03+0.00%
+$0.00 (+0.00%) • Dec 19
45
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.9
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.42
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.03
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CBSC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.03 – $0.03
TARGET (TP)$0.03
STOP LOSS$0.03
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.95
52W High$0.15
52W Low$0.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $41,397 | $135,055 | $82,405 | $75,576 | $32,438 |
| Gross Profit | $41,397 | $135,055 | $40,166 | $-73,665 | $22,629 |
| Gross Margin | 100.0% | 100.0% | 48.7% | -97.5% | 69.8% |
| Operating Income | $-1,327,787 | $-1,595,701 | $-2,101,913 | $-1,870,823 | $-2,942,614 |
| Net Income | $-1,680,696 | $-1,630,243 | $-2,106,577 | $-6,342,276 | $-4,327,682 |
| Net Margin | -4059.9% | -1207.1% | -2556.4% | -8391.9% | -13341.4% |
| EPS | $-0.01 | $-0.01 | $-0.02 | $-0.07 | $-0.06 |
Company Overview
Cardiac Biotech Solutions Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians. Cardiac Biotech Solutions' wholly owned U.S. subsidiary, My-Cardia (USA), Inc., develops ECG recording device worn by patients in an ambulatory setting for up to 30 days.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CBSCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2025
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q3 24
No data
Q4 24
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 13, 2025 | — | $-0.00 | — | — |
Q1 2025 | Feb 12, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | — | $-0.00 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.05 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-0.05 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CBSC
What is CBSC's current stock price?
Cardiac Biotech Solutions Inc. (CBSC) is currently trading at $0.03 per share. The stock has moved +0.00% today.
What is the analyst price target for CBSC?
No analyst price targets are currently available for this stock.
What sector is Cardiac Biotech Solutions Inc. in?
Cardiac Biotech Solutions Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.
What is CBSC's market cap?
Cardiac Biotech Solutions Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CBSC pay dividends?
No, Cardiac Biotech Solutions Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCPIVF
Captiva Verde Wellness Corp.
$0.02
Mkt Cap: $0.0B
ENZN
Enzon Pharmaceuticals, Inc.
$0.04
Mkt Cap: $0.0B
FZMD
Fuse Medical, Inc.
$0.02
Mkt Cap: $0.0B
IDXG
Interpace Biosciences, Inc.
$1.20
Mkt Cap: $0.0B
LIFD
LFTD Partners Inc.
$0.23
Mkt Cap: $0.0B
RMSL
REMSleep Holdings, Inc.
$0.00
Mkt Cap: $0.0B
RNVA
Rennova Health, Inc.
$0.00
Mkt Cap: $0.0B
RSCF
Reflect Scientific, Inc.
$0.05
Mkt Cap: $0.0B
TDSGF
Telo Genomics Corp.
$0.04
Mkt Cap: $0.0B
TGIFF
1933 Industries Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to CBSC for comparison